29 January 2018 - Deborah Wilkes
Archived
Japan's Takeda is boosting its presence in Russia by acquiring a range of OTC products from US-based Unipharm in a deal worth JPY40.8 billion (USD0.37 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.